Yüklüyor......
MicroRNAs in pancreatic cancer diagnosis and therapy
Pancreatic cancer remains a disease with very poor prognosis (only 5-6% of patients are still alive after five years). Attempts to improve the results of treatment of pancreatic cancer focus on a better understanding of the pathogenesis, and non-invasive diagnostic methods (genetic testing from peri...
Kaydedildi:
| Yayımlandı: | Cent Eur J Immunol |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Polish Society of Experimental and Clinical Immunology
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6305615/ https://ncbi.nlm.nih.gov/pubmed/30588176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/ceji.2018.80051 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|